Main news


Cancer and heart disease services put at risk by coronavirus response UK Biobank study suggests heart scans could help identify early damage and guide post-treatment care.



Recognizing efforts to reduce the burden of cardiovascular and kidney disease in type 2 diabetes Type 2 diabetes is one of the leading causes of premature cardiovascular death and significantly contributes to cardiovascular morbidity and kidney disease.



Statin Primary Prevention Trial in HIV Halted for Efficacy An international clinical trial testing statin therapy for primary cardiovascular prevention in people living with HIV has been stopped early due to strong evidence of efficacy and safety in this population.



Heart Disease Risk May Start Before Birth A woman's prepregnancy heart health is critical to both her health as well as the health of the children she gives birth to, according to researchers.



Cancer survivors may be at heightened risk of cardiovascular disease An international clinical trial testing statin therapy for primary cardiovascular prevention in people living with HIV has been stopped early due to strong evidence of efficacy and safety in this population.



High Biomarker Level Plus Diabetes Predict Bad PCI Outcomes Among patients with type 2 diabetes and coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI), those with a high platelet-to-lymphocyte ratio (PLR) at the time of their procedure had a significantly higher risk for major adverse cardiovascular and cerebrovascular events (MACCE) and stent thrombosis compared with similar patients with a low PLR during a median 2.4-year follow-up. Patients with PCI and a high PLR, but without type 2 diabetes, were not at increased risk for these outcomes compared with similar patients with a low PLR.



Dabigatran Recalled Over Potential Carcinogen Ascend Laboratories LLC is recalling 10 lots of the oral anticoagulant dabigatran etexilate capsules (75 mg and 150 mg) because of unacceptable levels of a potential carcinogen.



Treat to LDL Target or High-Intensity Statin for All With Clinical CAD: LODESTAR How secondary prevention statins are given to push LDL cholesterol levels lower, whether in a high-intensity statin regimen or by dosage titration to meet LDL targets, may make little difference to clinical outcomes, suggests a randomized trial.



Sports-Related Sudden Cardiac Arrest 'Extremely' Rare in Women Sports-related sudden cardiac arrest (Sr-SCA) appears to be extremely rare in women compared with men, despite similar characteristics and circumstances of occurrence, data from three European population-based registries suggest.



Oral PCSK9 Inhibitor Shows Encouraging LDL Lowering A new oral formulation of a PCSK9-inhibitor, cholesterol-lowering drug in development by Merck has shown encouraging results in a phase 2 study. The study was presented by Christie Ballantyne, MD, Baylor College of Medicine, Houston, Texas at the recent American College of Cardiology (ACC) Scientific Session/World Congress of Cardiology (WCC) 2023.


A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic Syndrome A growing appreciation of the pathophysiological interrelatedness of metabolic risk factors such as obesity and diabetes, chronic kidney disease, and cardiovascular disease has led to the conceptualization of cardiovascular-kidney-metabolic syndrome. The confluence of metabolic risk factors and chronic kidney disease within cardiovascular-kidney-metabolic syndrome is strongly linked to risk for adverse cardiovascular and kidney outcomes.


In memory of Umida Kabirovna Kamilova
In memory of Umida Kabirovna Kamilova November 21, 2023. Passed away at the age of 61. Professor Umida Kabirovna Kamilova, Doctor of Medical Sciences. She devoted her life and work to medicine.


Editorial Activity

cardiology book

ADA Advises New BP, Lipid Targets for People With Diabetes
ADA Advises New BP, Lipid Targets for People With Diabetes New more aggressive targets for blood pressure and lipids are among the changes to the annual American Diabetes Association (ADA) Standards of Care in Diabetes — 2023. The document, long considered the gold standard for care of the more than 100 million Americans living with diabetes and prediabetes, was published December 12 as a supplement in Diabetes Care. The guidelines are also accessible to doctors via an app; last year's standards were accessed more than 4 million times.


American Heart Association (AHA) Scientific Sessions 2022
American Heart Association (AHA) Scientific Sessions 2022 AHA’s Scientific Sessions 2022 in hybrid mode took place on Nov. 5-7, 2022, at McCormick Place Convention Center in Chicago, IL.


ACC Calls for More Career Flexibility in Cardiology
ACC Calls for More Career Flexibility in Cardiology A new statement from the American College of Cardiology (ACC) is calling for a greater degree of career flexibility in the specialty to promote cardiologists' personal and professional well-being and preserve excellence in patient care.


American Heart Associated
American Heart Associated A new statement from the American College of Cardiology (ACC) is calling for a greater degree of career flexibility in the specialty to promote cardiologists' personal and professional well-being and preserve excellence in patient care.



Prof. Aronow's career path
Prof. Aronow's career path Dear colleagues! The Cardioprogress Foundation presents the excerpts from the memoirs of the International Journal of Heart and Vascular Diseases editorial board member Wilbert S. Aronov, a cardiologist, professor of medicine, member of the FACC, FAHA, FACP, FCCP, FASPC, AGSF, FGSA. Dr. Wilbert Solomon Aronow was born in New York City on October 30, 1931. His parents were Russian Jewish immigrants. His grandparents were rabbis in Russia. Doctor Aronov dedicated his professional career to medicine.


World Heart Day 2022 in Iloilo
World Heart Day 2022 in Iloilo Iloilo province made history for hosting this year’s World Heart Day. It was chosen by the World Health Organization (WHO) as pilot area for the celebration. As highlight of the event, the whole façade of the Iloilo provincial capitol was illuminated on Thursday night, Sept. 29. The ceremonial event was led by Gov. Arthur Defensor Jr.; Department of Health (DOH) undersecretaries Dr. Kenneth Ronquillo and Atty. Charade Grande; DOH Western Visayas regional director, Dr. Adriano Zubaan; and representatives from WHO, Resolve to Save Lives, and World Heart Federation.


Climate change and health inequity a deadly mix for the most vulnerable: World Heart Federation
Climate change and health inequity a deadly mix for the most vulnerable: World Heart Federation Geneva, 29 September 2022 - On World Heart Day, the World Heart Federation (WHF) is calling for urgent action on climate change and health inequity, with millions more lives now at risk from cardiovascular disease, which is still the world’s biggest killer.